Property and Equipment

6 Months Ended

Jun. 30, 2023

Property and Equipment

Property and Equipment

Note 5. Property and Equipment

Property and equipment, net consisted of the following:

	June 30, 2023			December 31, 2022
Machinery and equipment	$	15		$	-
Computer hardware and software		15			-
VIVO DEMO/Clinical systems		52			-
Property and equipment, gross		82			-
Accumulated depreciation		(15	)		-
Property and equipment, net	$	67		$	-

Depreciation expense was $9 thousand and $15 thousand for the three and six months ended June 30, 2023, respectively.   Depreciation expense was $63 thousand and $179 thousand for the three and six months ended June 30, 2022, respectively. Due to the Company’s decision to discontinue enrollment of patients in its clinical trial and the RIF, the Company ceased manufacturing. The Company’s property and equipment was determined to be impaired as of June 30, 2022, resulting in an impairment charge of $1.5 million which was based on the actual cash proceeds received upon the disposal of the property and equipment in July 2022. The impairment charge of $1.5 million is included in restructuring and impairment charges in the condensed consolidated statement of operations for the three and six months ended June 30, 2022.